Vol 65 No 05

The authors of the analysis in JAMA Internal Medicine recommend that these medications be restricted to decreasing fracture risk.

Results from a longitudinal study suggest that bacteria in the cervicovaginal microbiome (CVM) may play a role in risk of progression of high-risk human papillomavirus (HR-HPV) to cervical precancer.

Accelerated biological aging was seen in women who had severe menopausal vasomotor symptoms (VMS) on enrollment in the Women’s Health Initiative Observational Study (WHI-OS), or late-occurring VMS (at enrollment but not at/during their reported menopause transition, according to a study in The Journal of Clinical Endocrinology & Metabolism.

“Black Maternal Health Momnibus Act of 2020” is led by Senator Kamala D. Harris (D-CA) and Representatives Lauren Underwood (IL-14) and Alma Adams (NC-12).

Navigating patient care in L&D during the global COVID-19 pandemic gives one resident cause for pause and reflection. How would it manifest in pregnancy?

During a routine office visit, a patient mentions that she recently submitted a saliva sample to 23andMe. The company performed BRCA analysis and the patient wants to discuss the results with you. How should you approach the discussion?

Liletta is under study in a prospective phase 3 clinical trial aimed at extending the approved duration of this levonorgestrel 52-mg IUS.

A diagnosis of vulvovaginal atrophy (VVA) in breast cancer survivors is associated with a significant increase in the burden of illness and social costs, according to an Italian Delphi Panel in the journal Supportive Care in Cancer. These findings are primarily due to a rise in comorbidities and resource utilization, but adequate treatment might reduce the impact of the condition.

In this piece, read ACOG’s Committee Opinion #785 on Screening and Management of Bleeding Disorders in Adolescents with Heavy Menstrual Bleeding, with expert commentary from Contemporary OB/GYN Board Member Dr. Paula J. Hillard.